Volume 25, Number 6—June 2019
Research
Performance of 2 Commercial Serologic Tests for Diagnosing Zika Virus Infection
Table 1
Panel | Sample characterization | No. samples | Mean time to collection after onset of fever, d (+ SD) |
---|---|---|---|
Panel performance evaluation 3–20 days after onset | |||
Zika virus subgroup | Positive Zika virus | 90 | 10 + 6 |
Non–Zika virus subgroup | Negative Zika virus with confirmed dengue virus infection | 35 | 10 + 3 |
Negative Zika virus with confirmed chikungunya virus infection | 29 | 13 + 3 | |
Negative Zika virus, dengue virus, chikungunya virus | 45 | 11 + 5 | |
Total panel performance |
199 |
10 + 5 |
|
Panel IgM–IgG kinetics 0–300 days after onset | |||
Positive Zika virus | 300* | Minimum 0, maximum 300, median 20, interquartile range 4–81 |
*300 samples from 124 patients, including the 90 positive Zika virus samples in the first panel.
Page created: May 20, 2019
Page updated: May 20, 2019
Page reviewed: May 20, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.